0001181431-13-055307.txt : 20131028 0001181431-13-055307.hdr.sgml : 20131028 20131028165518 ACCESSION NUMBER: 0001181431-13-055307 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131023 FILED AS OF DATE: 20131028 DATE AS OF CHANGE: 20131028 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDIVATION, INC. CENTRAL INDEX KEY: 0001011835 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133863260 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 525 MARKET STREET STREET 2: 36TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 415-543-3470 MAIL ADDRESS: STREET 1: 525 MARKET STREET STREET 2: 36TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 FORMER COMPANY: FORMER CONFORMED NAME: ORION ACQUISITION CORP II DATE OF NAME CHANGE: 19960408 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cohen Cheryl CENTRAL INDEX KEY: 0001529371 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32836 FILM NUMBER: 131173628 MAIL ADDRESS: STREET 1: C/O MEDIVATION, INC. STREET 2: 201 SPEAR ST., 3RD FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 4 1 rrd393446.xml COHEN - SAME DALE SALE (10/23/2013) X0306 4 2013-10-23 0 0001011835 MEDIVATION, INC. MDVN 0001529371 Cohen Cheryl C/O MEDIVATION, INC. 525 MARKET ST., 36TH FLOOR SAN FRANCISCO CA 94105 0 1 0 0 Chief Commercial Officer Common Stock 2013-10-23 4 M 0 25000 9.605 A 50439 D Common Stock 2013-10-23 4 S 0 25000 63.0498 D 25439 D Common Stock 2013-10-24 4 M 0 25000 9.605 A 50439 D Common Stock 2013-10-24 4 S 0 23000 65.4047 D 27439 D Common Stock 2013-10-24 4 S 0 2000 66.019 D 25439 D Stock Option (Right to Buy) 9.605 2013-10-23 4 D 0 25000 0.00 D 2021-09-15 Common Stock 25000 350000 D Stock Option (Right to Buy) 9.605 2013-10-24 4 D 0 25000 0.00 D 2021-09-15 Common Stock 25000 325000 D The shares were sold pursuant to a 10b5-1 Plan. The shares were sold at prices ranging from $63.03 to $63.075. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares subject to the option shall become vested according to the following schedule: 25% of the shares subject to the option (rounded down to the next whole number of shares) shall vest on September 15, 2012, and 1/48th of the shares subject to the option (rounded down to the next whole number of shares) shall vest of the first day of each full month thereafter. The shares were sold at prices ranging from $65.00 to $65.87. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. /s/ Patrick Machado, Attorney-in-fact 2013-10-28